Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial
Takashima, Hiroyuki, Yoshida, Yoshinori, Nagura, Chinami, Furukawa, Tetsuya, Tei, Ritsukou, Maruyama, Takashi, Maruyama, Noriaki, Abe, MasanoriLanguage:
english
Journal:
Diabetes and Vascular Disease Research
DOI:
10.1177/1479164118782872
Date:
June, 2018
File:
PDF, 85 KB
english, 2018